Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

Scholarships to Attend 21st Spring School on Immunology

October 10, 2025Deutsche Gesellschaft für Immunologie

IUIS 2025 Congress Recordings Now Available on ImmunoHub

September 30, 2025

Highlights from our Junior Community Scientific Symposium

September 26, 2025Early Career Committee (ECC), European Federation of Immunological Societies (EFIS) and 1 more

Opportunities from the International Science Council (ISC)

September 24, 2025

Funding Opportunity: ICLAS invites its members to apply for financial support

September 19, 2025Veterinary Immunology Committee (VIC)

IUIS 2025 Congress Recordings – Coming Soon on Immunohub!

September 9, 2025

IUIS Education Committee Brings You a Symposium

August 8, 2025Education Committee (EDU)

Visit the IUIS Booth at the IUIS 2025 Congress!

July 29, 2025

A message from IUIS President, Dr Miriam Merad

July 2, 2025